Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Tuesday. $342.45 million flowed into the stock on the tick-up and $419.71 million flowed out of the stock on the tick-down, for a money net flow of $77.26 million out of the stock. Of all companies tracked, UnitedHealth Group had the 11th highest net out-flow for the day. UnitedHealth Group traded up $4.26 for the day and closed at $232.90

Several equities research analysts recently commented on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 target price on shares of UnitedHealth Group in a report on Tuesday. Wells Fargo & Co reiterated an “outperform” rating and set a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Evercore ISI reiterated an “outperform” rating and set a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday. Finally, Citigroup raised their target price on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $229.54.

The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market cap of $225,180.00, a price-to-earnings ratio of 26.47, a PEG ratio of 1.54 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the business earned $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

In other news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 over the last quarter. Company insiders own 0.89% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $110,000. Bruderman Asset Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at approximately $121,000. Finally, Acrospire Investment Management LLC boosted its position in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Investors Sell UnitedHealth Group (UNH) on Strength (UNH)” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/investors-sell-unitedhealth-group-unh-on-strength-unh/1809840.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.